US Bancorp
ALT icon

US Bancorp’s Altimmune ALT Stock Holding History

US Bancorp’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74K Buy
890
+331
+59% +$1.41K ﹤0.01% 3730
2025
Q4 		$2.02K Buy
559
+508
+996% +$2.21K ﹤0.01% 3750
2025
Q3 		$192 Sell
51
-3,820
-99% -$14.7K ﹤0.01% 3946
2025
Q2 		$15K Buy
3,871
+2,593
+203% +$14K ﹤0.01% 3287
2025
Q1 		$6.39K Sell
1,278
-127
-9% -$804 ﹤0.01% 3583
2024
Q4 		$10.1K Buy
1,405
+655
+87% +$5K ﹤0.01% 3406
2024
Q3 		$4.61K Hold
750
– – ﹤0.01% 3595
2024
Q2 		$4.99K Sell
750
-19,067
-96% -$141K ﹤0.01% 3515
2024
Q1 		$202K Buy
+19,817
New +$202K ﹤0.01% 2004
2023
Q2 		– Sell
-500
Closed -$2.11K – 3988
2023
Q1 		$2.11K Sell
500
-391
-44% -$4.64K ﹤0.01% 3743
2022
Q4 		$14.7K Sell
891
-1,093
-55% -$12.3K ﹤0.01% 3158
2022
Q3 		$25K Hold
1,984
– – ﹤0.01% 2910
2022
Q2 		$23K Buy
1,984
+891
+82% +$5.5K ﹤0.01% 2964
2022
Q1 		$7K Buy
+1,093
New +$8.05K ﹤0.01% 3492
2020
Q3 		– Sell
-1,145
Closed -$12K – 3692
2020
Q2 		$12K Buy
+1,145
New +$6.29K ﹤0.01% 3022
2014
Q1 		– Sell
-7
Closed -$4K – 3460
2013
Q4 		$4K Hold
7
– – ﹤0.01% 3162
2013
Q3 		$4K Hold
7
– – ﹤0.01% 3087
2013
Q2 		$3K Buy
+7
New +$3.47K ﹤0.01% 3078

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

US Bancorp's ALT Position: Q1 2026 in Review

US Bancorp increased its Altimmune (ALT) stake by 59% in Q1 2026, buying an estimated $1.41K and bringing the position to 890 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #3730.

US Bancorp first reported a position in ALT in Q2 2013 and has held it in 18 quarters since. The position peaked at $202K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • US Bancorp held 890 shares of Altimmune worth $2.74K as of Q1 2026.
  • US Bancorp bought 331 Altimmune shares in Q1 2026, an estimated $1.41K.
  • Altimmune made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3730 holding.
  • US Bancorp first reported a position in Altimmune in Q2 2013 and has held it in 18 quarters since.
  • US Bancorp's Altimmune position peaked at $202K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.